featured
Effects of Dapagliflozin on Myocardial Function and Metabolism in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of 6 Weeks Treatment With Dapagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, on Myocardial Function and Metabolism in Patients With Type 2 Diabetes: A Randomized Placebo-Controlled Exploratory Study
Diabetes Obes Metab 2021 Feb 24;[EPub Ahead of Print], J Oldgren, S Laurila, A Åkerblom, A Latva-Rasku, E Rebelos, H Isackson, M Saarenhovi, O Eriksson, K Heurling, E Johansson, U Wilderäng, C Karlsson, R Esterline, E Ferrannini, J Oscarsson, P NuutilaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.